132 related articles for article (PubMed ID: 37340862)
21. The Serum Ferritin Level Is Associated with the Treatment Responsivity for Rapidly Progressive Interstitial Lung Disease with Amyopathic Dermatomyositis, Irrespective of the Anti-MDA5 Antibody Level.
Osawa T; Morimoto K; Sasaki Y; Matsuda S; Yamana K; Yano R; Uchiyama T; Goto H
Intern Med; 2018 Feb; 57(3):387-391. PubMed ID: 29093381
[TBL] [Abstract][Full Text] [Related]
22. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
[TBL] [Abstract][Full Text] [Related]
23. Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease.
Xu A; Ye Y; Fu Q; Lian X; Chen S; Guo Q; Lu LJ; Dai M; Lv X; Bao C
Rheumatology (Oxford); 2021 Jul; 60(7):3343-3351. PubMed ID: 33331866
[TBL] [Abstract][Full Text] [Related]
24. [Clinically amyopathic dermatomyositis : a rare entity associated with acute and severe interstitial lung disease].
Debrus C; Calmes D; Von Frenckell C; Duysinx B; Cataldo D; Corhay JL; Louis R; Guiot J
Rev Med Liege; 2023 Jul; 78(7-8):441-447. PubMed ID: 37560958
[TBL] [Abstract][Full Text] [Related]
25. Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis.
Matsushita T; Mizumaki K; Kano M; Yagi N; Tennichi M; Takeuchi A; Okamoto Y; Hamaguchi Y; Murakami A; Hasegawa M; Kuwana M; Fujimoto M; Takehara K
Br J Dermatol; 2017 Feb; 176(2):395-402. PubMed ID: 27452897
[TBL] [Abstract][Full Text] [Related]
26. An Autopsy Case of Anti-melanoma Differentiation-associated Gene-5 Antibody-positive Clinical Amyopathic Dermatomyositis Complicated by Rapidly Progressive Interstitial Lung Disease.
Yoshida N; Kaieda S; Tomozoe K; Tajiri M; Wakasugi D; Okamoto M; Tominaga M; Ida H; Hoshino T
Intern Med; 2016; 55(12):1653-9. PubMed ID: 27301523
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy.
Abe Y; Kusaoi M; Tada K; Yamaji K; Tamura N
Rheumatology (Oxford); 2020 Apr; 59(4):767-771. PubMed ID: 31504956
[TBL] [Abstract][Full Text] [Related]
28. Melanoma differentiation-associated gene 5 amyopathic dermatomyositis following an acute Mycoplasma pneumoniae infection: a case report.
Hoey J; Solomon JL; Kim B; Carsons S; Nusbaum J
J Med Case Rep; 2022 Nov; 16(1):401. PubMed ID: 36316755
[TBL] [Abstract][Full Text] [Related]
29. A case of anti-MDA5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment.
Koichi Y; Aya Y; Megumi U; Shunichi K; Masafumi S; Hiroaki M; Masahiko K; Shinsuke K; Manabu U; Kenichiro H; Fumiaki A; Nozomi A; Toshitaka M; Masayoshi Y; Chikako K; Yoshinao M; Tatsuo S; Masahiko K
Mod Rheumatol; 2017 May; 27(3):536-540. PubMed ID: 25698373
[TBL] [Abstract][Full Text] [Related]
30. Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis Complicated by Unilateral Right-sided Interstitial Lung Disease.
Kori M; Awano N; Inomata M; Kuse N; Tone M; Yoshimura H; Jo T; Takada K; Kumasaka T; Takemura T; Izumo T
Intern Med; 2020; 59(3):401-408. PubMed ID: 32009089
[TBL] [Abstract][Full Text] [Related]
31. Clinically amyopathic dermatomyositis associated with anti-MDA5 antibody.
Parperis K; Kiyani A
BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29301801
[TBL] [Abstract][Full Text] [Related]
32. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.
Ye Y; Fu Q; Wang R; Guo Q; Bao C
J Clin Lab Anal; 2019 Oct; 33(8):e22978. PubMed ID: 31301087
[TBL] [Abstract][Full Text] [Related]
33. [A case of amyopathic dermatomyositis with acute interstitial pneumonia (DAD pattern)].
Kaji K; Igarashi A; Hamaguchi Y; Sato S
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Apr; 27(2):103-7. PubMed ID: 15164931
[TBL] [Abstract][Full Text] [Related]
34. Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease.
Motegi SI; Sekiguchi A; Toki S; Kishi C; Endo Y; Yasuda M; Ikeuchi H; Sakairi T; Hara K; Yamaguchi K; Maeno T; Hiromura K; Ishikawa O
Eur J Dermatol; 2019 Oct; 29(5):511-517. PubMed ID: 31617496
[TBL] [Abstract][Full Text] [Related]
35. High-dose intravenous immunoglobulin therapy for rapidly progressive interstitial pneumonitis accompanied by anti-melanoma differentiation-associated gene 5 antibody-positive amyopathic dermatomyositis.
Hamada-Ode K; Taniguchi Y; Kimata T; Kawaguchi Y; Shimamura Y; Kuwana M; Fujimoto S; Terada Y
Eur J Rheumatol; 2015 Jun; 2(2):83-85. PubMed ID: 27708934
[TBL] [Abstract][Full Text] [Related]
36. Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review.
González-Moreno J; Raya-Cruz M; Losada-Lopez I; Cacheda AP; Oliver C; Colom B
Rheumatol Int; 2018 Jul; 38(7):1293-1296. PubMed ID: 29417209
[TBL] [Abstract][Full Text] [Related]
37. Double anti-PL-7 and anti-MDA-5 positive Amyopathic Dermatomyositis with rapidly progressive interstitial lung disease in a Hispanic patient.
Li ZY; Gill E; Mo F; Reyes C
BMC Pulm Med; 2020 Aug; 20(1):220. PubMed ID: 32799827
[TBL] [Abstract][Full Text] [Related]
38. Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review.
McPherson M; Economidou S; Liampas A; Zis P; Parperis K
Semin Arthritis Rheum; 2022 Apr; 53():151959. PubMed ID: 35134633
[TBL] [Abstract][Full Text] [Related]
39. Anti-MDA5 positive clinically amyopathic dermatomyositis presenting with severe cardiomyopathy.
Pau-Charles I; Moreno PJ; Ortiz-Ibáñez K; Lucero MC; Garcia-Herrera A; Espinosa G; Nicolás JM; Castro P; Grau JM; Casciola-Rosen L; Mascaró JM
J Eur Acad Dermatol Venereol; 2014 Aug; 28(8):1097-1102. PubMed ID: 25243267
[TBL] [Abstract][Full Text] [Related]
40. Rituximab in the Treatment of Interstitial Lung Diseases Related to Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis: A Systematic Review.
He C; Li W; Xie Q; Yin G
Front Immunol; 2021; 12():820163. PubMed ID: 35116041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
